Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
4.420
-0.060 (-1.34%)
At close: Nov 20, 2024, 4:00 PM
4.340
-0.080 (-1.81%)
After-hours: Nov 20, 2024, 6:39 PM EST
Adaptive Biotechnologies Market Cap
Adaptive Biotechnologies has a market cap or net worth of $652.30 million as of November 21, 2024. Its market cap has decreased by -6.44% in one year.
Market Cap
652.30M
Enterprise Value
609.43M
1-Year Change
-6.44%
Ranking
Category
Stock Price
$4.42
Market Cap Chart
Since June 27, 2019, Adaptive Biotechnologies's market cap has decreased from $4.77B to $652.30M, a decrease of -86.34%. That is a compound annual growth rate of -30.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 652.30M | -8.05% |
| Dec 29, 2023 | 709.39M | -35.07% |
| Dec 30, 2022 | 1.09B | -72.41% |
| Dec 31, 2021 | 3.96B | -51.03% |
| Dec 31, 2020 | 8.09B | 117.39% |
| Dec 31, 2019 | 3.72B | -22.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orthofix Medical | 715.75M |
| Anavex Life Sciences | 698.72M |
| CorMedix | 671.70M |
| Arbutus Biopharma | 661.33M |
| Dianthus Therapeutics | 659.12M |
| agilon health | 655.11M |
| IRADIMED CORPORATION | 649.51M |
| Butterfly Network | 648.35M |